Department of Medicine Grand Rounds
When scientists discovered that GLP-1 agonists like semaglutide (which sells under the brand names Ozempic and Wegovy) led to substantial weight loss, the landscape of obesity management changed dramatically. For patients with obesity, the range of treatment options – from lifestyle changes to medication to surgery to combination approaches – can be confusing and daunting. In next week’s Grand Rounds, Jonathan Carter and Diana Thiara will help us navigate the therapeutic options for obesity in 2023 and beyond.
Jonathan Carter, MD, is professor of Surgery and the program director of the Advanced GI Minimally Invasive/Bariatric Surgery Fellowship in the Division of General Surgery at UCSF Health. He is an international expert in bariatric surgery and minimally invasive advanced approaches such as laparoscopic and robotic surgery. Jonathan is a fellow of the American College of Surgeons and American Society for Metabolic and Bariatric Surgery.
Diana Thiara, MD, is assistant professor of Medicine and the medical director of the Medical Weight Management Clinic in the Division of General Internal Medicine at UCSF Health. Her work focuses on innovative patient programs for weight management and wellness. Diana is a Diplomate of the American Board of Obesity Medicine.
This Grand Rounds will be Zoom-only. Watch live using the link below or at your convenience on our YouTube channel.
Join from a PC, Mac, iPad, iPhone or Android device by clicking:
Webinar ID: 925 0799 1004
Or join by phone by dialing (for higher quality, dial a number based on your current location):
US: +1 669 900 6833 or +1 346 248 7799 or +1 312 626 6799 or
+1 646 558 8656 or +1 253 215 8782 or +1 301 715 8592
International numbers available: https://ucsf.zoom.us/u/abBh6VatYU
The session will be recorded for later play here.